We are live on ! Find out more
WX

WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS
WX

Delisted

WX was delisted on the 10th of December, 2015.

164 hedge funds and large institutions have $2.17B invested in WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS in 2014 Q1 according to their latest regulatory filings, with 22 funds opening new positions, 52 increasing their positions, 76 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

16% more first-time investments, than exits

New positions opened: 22 | Existing positions closed: 19

0% more funds holding

Funds holding: 164164 (0)

5% less capital invested

Capital invested by funds: $2.28B → $2.17B (-$111M)

29% less funds holding in top 10

Funds holding in top 10: 75 (-2)

29% less call options, than puts

Call options by funds: $856K | Put options by funds: $1.21M

32% less repeat investments, than reductions

Existing positions increased: 52 | Existing positions reduced: 76

Holders
164
Holders Change
Holders Change %
0%
% of All Funds
4.73%
Holding in Top 10
5
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-28.57%
% of All Funds
0.14%
New
22
Increased
52
Reduced
76
Closed
19
Calls
$856K
Puts
$1.21M
Net Calls
-$349K
Net Calls Change
-$1.2M
Name Holding Trade Value Shares
Change
Change in
Stake
SAM
176
Symphony Asset Management
California
-$398K -10,364 Closed
HSA
177
Hussman Strategic Advisors
Maryland
-$384K -10,000 Closed
TMAM
178
Tokio Marine Asset Management
Japan
-$380K -9,900 Closed
NCCM
179
Nine Chapters Capital Management
New Jersey
-$319K -8,300 Closed
Jane Street
180
Jane Street
New York
-$279K -7,256 Closed
AP
181
Advisors Preferred
Maryland
-$21K -570 Closed
EWM
182
Elite Wealth Management
Washington
-$5K -137 Closed
WA
183
WFG Advisors
Texas
-$3K -73 Closed

WX Hedge Fund Activity: Q1 2014 in Review

164 of the 3,464 institutional investors tracked by Wall St. Rank reported a position in WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS (WX) for Q1 2014, worth a combined $2.17B — down 4.8% from $2.28B a quarter earlier.

Buyers outnumbered sellers: 22 funds opened new WX positions and 19 closed out — a net gain of 3 holders — while 52 added to existing stakes and 76 trimmed.

The largest buyer was Acadian Asset Management, adding an estimated $66.4M. The largest seller was Fidelity International, cutting an estimated $43.4M.

  • 164 institutional investors held WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS (WX) as of Q1 2014, unchanged from Q4 2013.
  • Funds reported $2.17B of WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS stock for Q1 2014, down 4.8% quarter-over-quarter.
  • 22 funds opened new WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS positions in Q1 2014 and 19 closed out, a net change of +3 holders.
  • The largest WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS buyer in Q1 2014 was Acadian Asset Management, an estimated $66.4M added.
  • The largest WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS seller in Q1 2014 was Fidelity International, an estimated $43.4M sold.

Based on aggregated 13F filings for Q1 2014.